Phase 1:
Enhance the efficiency of clinical trial rollout through the creation
of a training curriculum, materials, and anatomical simulators.

Phase 2:
Design and develop a commercial-ready device and injection procedure that improves usability, clinical consistency, and
delivery precision.

The reengineered drug delivery device decreases procedure time and improves injection consistency for the ophthalmologist.